Total Payments
$45,848
2024 Payments
$111.51
Companies
9
Transactions
41
Medicare Patients
1,987
Medicare Billing
$526,810
Payment Breakdown by Category
Other$16,770 (36.6%)
Travel$14,971 (32.7%)
Consulting$12,848 (28.0%)
Food & Beverage$1,259 (2.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $15,770 | 3 | 34.4% |
| Travel and Lodging | $14,971 | 13 | 32.7% |
| Consulting Fee | $12,848 | 7 | 28.0% |
| Food and Beverage | $1,259 | 16 | 2.7% |
| Honoraria | $1,000 | 2 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $23,834 | 6 | $0 (2018) |
| Veloxis Pharmaceuticals, Inc. | $13,466 | 24 | $0 (2022) |
| Dova Pharmaceuticals | $4,942 | 5 | $0 (2018) |
| La Jolla Pharmaceutical Company | $2,840 | 1 | $0 (2023) |
| VERTEX PHARMACEUTICALS INCORPORATED | $508.33 | 1 | $0 (2019) |
| Takeda Pharmaceuticals U.S.A., Inc. | $119.04 | 1 | $0 (2023) |
| Merck Sharp & Dohme LLC | $111.51 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $17.31 | 1 | $0 (2019) |
| Relypsa, Inc. | $10.89 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $111.51 | 1 | Merck Sharp & Dohme LLC ($111.51) |
| 2023 | $2,959 | 2 | La Jolla Pharmaceutical Company ($2,840) |
| 2022 | $1,000 | 2 | Veloxis Pharmaceuticals, Inc. ($1,000) |
| 2021 | $500.00 | 1 | Veloxis Pharmaceuticals, Inc. ($500.00) |
| 2020 | $7,030 | 13 | Veloxis Pharmaceuticals, Inc. ($7,030) |
| 2019 | $5,472 | 11 | Veloxis Pharmaceuticals, Inc. ($4,936) |
| 2018 | $5,037 | 6 | Dova Pharmaceuticals ($4,942) |
| 2017 | $23,738 | 5 | SANOFI-AVENTIS U.S. LLC ($23,738) |
All Payment Transactions
41 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/15/2024 | Merck Sharp & Dohme LLC | PREVYMIS (Drug) | Food and Beverage | In-kind items and services | $111.51 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 06/05/2023 | Takeda Pharmaceuticals U.S.A., Inc. | LIVTENCITY (Drug) | Food and Beverage | In-kind items and services | $119.04 | General |
| Category: IMMUNOLOGY | ||||||
| 01/18/2023 | La Jolla Pharmaceutical Company | GIAPREZA (Drug) | Consulting Fee | Cash or cash equivalent | $2,840.00 | General |
| Category: EMERGENT HYPOTENSION | ||||||
| 04/14/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Immunosuppresant | ||||||
| 01/16/2022 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Honoraria | Cash or cash equivalent | $500.00 | General |
| Category: Immunosuppresant | ||||||
| 01/26/2021 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: Immunosuppresant | ||||||
| 10/27/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Immunosuppressant | ||||||
| 10/27/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $12.00 | General |
| Category: Immunosuppressant | ||||||
| 05/06/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $1,007.00 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $375.00 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Travel and Lodging | Cash or cash equivalent | $335.16 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $50.00 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $29.16 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $23.86 | General |
| Category: Immunosuppressant | ||||||
| 01/12/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $22.80 | General |
| Category: Immunosuppressant | ||||||
| 01/11/2020 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: Immunosuppressant | ||||||
| 11/12/2019 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: NEPHROLOGY | ||||||
| 10/24/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Travel and Lodging | In-kind items and services | $844.94 | General |
| Category: Immunosuppressant | ||||||
| 10/24/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Travel and Lodging | In-kind items and services | $350.00 | General |
| Category: Immunosuppressant | ||||||
| 10/24/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Immunosuppressant | ||||||
| 10/24/2019 | Veloxis Pharmaceuticals, Inc. | Envarsus (Drug), Envarsus | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $25.00 | General |
| Category: Immunosuppressant | ||||||
| 05/22/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Consulting Fee | Cash or cash equivalent | $508.33 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 347 | 689 | $367,079 | $93,535 |
| 2022 | 11 | 467 | 1,062 | $501,357 | $126,427 |
| 2021 | 13 | 541 | 1,019 | $549,781 | $138,705 |
| 2020 | 14 | 632 | 1,198 | $662,136 | $168,142 |
Total Patients
1,987
Total Services
3,968
Medicare Billing
$526,810
Procedure Codes
47
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 50360 | Transplantation of donor kidney | Facility | 2023 | 20 | 20 | $145,577 | $38,403 | 26.4% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 85 | 340 | $69,020 | $21,153 | 30.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 79 | 146 | $47,922 | $10,738 | 22.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 62 | 78 | $30,186 | $7,886 | 26.1% |
| 36831 | Removal of blood clot from hemodialysis graft | Facility | 2023 | 14 | 14 | $31,066 | $6,601 | 21.2% |
| 37607 | Tying or banding of surgically created artery-vein connection | Facility | 2023 | 18 | 18 | $18,216 | $3,114 | 17.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 38 | 42 | $8,610 | $2,656 | 30.8% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 16 | 16 | $9,072 | $2,176 | 24.0% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2023 | 15 | 15 | $7,410 | $808.05 | 10.9% |
| 50360 | Transplantation of donor kidney | Facility | 2022 | 27 | 27 | $195,900 | $49,590 | 25.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 114 | 601 | $121,004 | $33,858 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 96 | 175 | $52,360 | $12,569 | 24.0% |
| 36831 | Removal of blood clot from hemodialysis graft | Facility | 2022 | 15 | 15 | $33,285 | $6,971 | 20.9% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 50 | 63 | $24,183 | $6,625 | 27.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 54 | 69 | $20,576 | $5,699 | 27.7% |
| 37607 | Tying or banding of surgically created artery-vein connection | Facility | 2022 | 20 | 20 | $20,240 | $3,666 | 18.1% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 38 | 39 | $11,066 | $3,056 | 27.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 18 | 18 | $10,110 | $2,548 | 25.2% |
| 50323 | Preparation of donor kidney for transplantation | Facility | 2022 | 19 | 19 | $9,386 | $962.97 | 10.3% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 16 | 16 | $3,247 | $881.73 | 27.2% |
| 50360 | Transplantation of donor kidney | Facility | 2021 | 32 | 32 | $230,048 | $58,673 | 25.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 103 | 433 | $85,245 | $24,444 | 28.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 114 | 233 | $65,745 | $17,972 | 27.3% |
| 36831 | Removal of blood clot from dialysis graft, open procedure | Facility | 2021 | 22 | 22 | $49,373 | $10,381 | 21.0% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 56 | 70 | $20,450 | $5,747 | 28.1% |
About Kenneth Brayman, M.D,
Kenneth Brayman, M.D, is a Surgery healthcare provider based in Charlottesville, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1306915921.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Kenneth Brayman, M.D, has received a total of $45,848 in payments from pharmaceutical and medical device companies, with $111.51 received in 2024. These payments were reported across 41 transactions from 9 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($15,770).
As a Medicare-enrolled provider, Brayman has provided services to 1,987 Medicare beneficiaries, totaling 3,968 services with total Medicare billing of $526,810. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Ad
Practice Information
- Specialty Surgery
- Other Specialties Transplant Surgery
- Location Charlottesville, VA
- Active Since 11/07/2006
- Last Updated 08/06/2015
- Taxonomy Code 208600000X
- Entity Type Individual
- NPI Number 1306915921
Products in Payments
- THYMOGLOBULIN (Drug) $23,834
- Envarsus (Drug) $13,466
- Doptelet (Drug) $4,942
- GIAPREZA (Drug) $2,840
- LIVTENCITY (Drug) $119.04
- PREVYMIS (Drug) $111.51
- JYNARQUE (Drug) $17.31
- Veltassa (Drug) $10.89
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Surgery Doctors in Charlottesville
Behzad Farivar, Md, MD
Surgery — Payments: $28,663
Surgery $28,663
Carlin Williams, M.d, M.D
Surgery — Payments: $26,623
Surgery $26,623
Peter Hallowell, Md, MD
Surgery — Payments: $13,480
Surgery $13,480
Charles Friel, Md, MD
Surgery — Payments: $11,828
Surgery $11,828
Dr. Christine Ibilibor, M.d., M.sc, M.D., M.SC
Surgery — Payments: $10,992
Surgery $10,992
John Carl, Md, MD
Surgery — Payments: $10,836
Surgery $10,836